Duration of corticosteroid therapy in giant cell arteritis

J Rheumatol. May-Jun 1980;7(3):361-4.


A follow-up study of 29 patients with giant cell arteritis (GCA) was undertaken to determine the duration of corticosteroid treatment. In 20 patients the diagnosis was confirmed by biopsy of a temporal artery (Group 1). In 9 patients GCA was evident clinically (Group 2). Treatment was continued until reductions in corticosteroid dosage no longer resulted in clinical evidence of GCA. The mean duration of corticosteroid treatment was 6 yr. The diagnosis of GCA should be confirmed by means of a temporal artery biopsy before treatment is begun because it may commit the patient to years of corticosteroid treatment.

MeSH terms

  • Aged
  • Follow-Up Studies
  • Giant Cell Arteritis / drug therapy*
  • Heart Failure / mortality
  • Humans
  • Long-Term Care
  • Middle Aged
  • Myocardial Infarction / mortality
  • Prednisone / adverse effects
  • Prednisone / therapeutic use*


  • Prednisone